Re. The biggest laugh19 Oct 2018 09:51
THE RNS issued on June 13th informed shareholders that the company had a strong balance sheet. The commitment and the costs for a stage III trial was known at that stage, and management were obviously looking for a partner. However, in the event that they did not find a partner, and decided not to commercialise the CSD 500, the funds were not there and the statement was a misrepresentation, in fact meaningless, and gave a false impression unless the company were confident of securing a deal. On June 13th the share price was around 34p. A placing could have been done then at 28p/30p by the issuance of 20 to 25 million shares. Instead massive share price destruction through disappointing news and disastrous interview with the press in September, foloowed by steady price decline results in a placing at 7p through the issuance of over 70 million shares. I'm holding these shares in an account for my adolesecent son. Maybe the product will see the light of day before he needs to use it. Woeful!